July 19, 2013
Takeda Pharmaceutical and US-based Zinfandel Pharmaceuticals announced on July 18 that findings of a risk assignment algorithm using the TOMM40 biomarker for identifying the risk of Alzheimer’s disease (AD) showed positive predictive and negative predictive values in the range of...read more